Lea-Kristin Nagler (L Nagler, Nagler Lea-Kristin)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Ejection Fraction

End Stage Renal Disease

Clinical Decision Support

Rheumatoid Arthritis Patients

Top Venues

Rheumatology international

Scandinavian journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Labinsky Hannah, Lea-Kristin Nagler, Krusche Martin, Sebastian Griewing, Aries Peer, Kroiß Anja, Patrick-Pascal Strunz, Sebastian Kuhn, Schmalzing Marc, Michael Gernert, Johannes Knitza
Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study. Rheumatology international (2024)
Labinsky Hannah, Lea-Kristin Nagler, Krusche Martin, Sebastian Griewing, Aries Peer, Kroiß Anja, Patrick-Pascal Strunz, Sebastian Kuhn, Schmalzing Marc, Michael Gernert, Johannes Knitza
Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study. Rheumatology international (2024)
S Hüper, Lea-Kristin Nagler, Patrick-Pascal Strunz, Matthias Fröhlich, Labinsky Hannah, Schmalzing Marc, Michael Gernert
Lymphoma in Sjögren's syndrome: no need for repetitive screening ultrasounds of the major salivary glands and neck in asymptomatic patients. Scandinavian journal of rheumatology (2024)
Labinsky Hannah, Lea-Kristin Nagler, Krusche Martin, Sebastian Griewing, Aries Peer, Kroiß Anja, Patrick-Pascal Strunz, Sebastian Kuhn, Schmalzing Marc, Michael Gernert, Johannes Knitza
Correction: Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study. Rheumatology international (2024)
Labinsky Hannah, Lea-Kristin Nagler, Krusche Martin, Sebastian Griewing, Aries Peer, Kroiß Anja, Patrick-Pascal Strunz, Sebastian Kuhn, Schmalzing Marc, Michael Gernert, Johannes Knitza
Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study. Rheumatology international (2024)